Thank you for donating!

You can donate using the following services.

UK LSD Patient Collaborative Group


NPUK is a member of the UK LSD Patient Collaborative Group. The collaborative is comprised of patient organisations representing those affected by lysosomal storage disorders (LSDs) who have joined forces to create a strong lobbying and action group for LSD patients and their families in the UK.

The collaborative aims to provide an understanding of LSDs by working in partnership to advance standards of care and to enhance the wellbeing of those affected by LSDs. See below for a list of the members and to find out more go to

Further information
LSD UK Patient Organisation Secretariat
Tanya Collin-Histed
Chief Executive
Gauchers Association
8 Silver Street
Gloucestershire GL11 4ND
Tel: 00 44 1453 549231
Fax: 00 44 1453 549231


agsd_small2-940x635The AGSD provides support and help for individuals and families affected by Glycogen Storage Disease (GSD).

Battens Disease Family Association

bdfa_logo_newThe Batten Disease Family Association (BDFA) is a national charity which aims to support families, raise awareness and facilitate research into the group of devastating neurodegenerative diseases commonly known as Batten Disease.

The CATS Foundation

cats_logoThe CATS Foundation supports families affected by Tay-Sachs by offering equipment, information, and funding for research.

The Gauchers Association

gauchers-logoThe Gauchers Association promotes awareness, pioneers research and provides support and information for those affected by Gaucher disease.

The MPS Society

mpslogoThe Society for Mucopolysaccharide Diseases (The MPS Society) is a voluntary support group founded in 1982, which represents from throughout the UK over 1200 children and adults suffering from Mucopolysaccharide and Related Lysosomal Diseases including Fabry Disease, their families, carers and professionals.


WeNP-UK logo, NPUK, are a charitable organisation dedicated to making a positive difference to the lives of those affected by Niemann-Pick diseases. We raise much needed awareness, provide practical and emotional support, advice and information and facilitate research into potential therapies.

Save Babies Through Screening Foundation UK

sbuk-logoSBUK work in the UK to save and improve the lives of babies through new-born screening and treatment of a wide range of genetic diseases.

Latest news


CTD Holdings Announces Plan to Launch Clinical Trial of Trappsol® Cyclo™ in Alzheimer’s Disease

ALACHUA, FL – (Globe Newswire) – March 14, 2019 – CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical need, announced today that the company has initiated planning for a Phase I clinical trial for treatment of Alzheimer’s Disease. The trial will use Trappsol® Cyclo™, the company’s proprietary formulation of hydroxypropyl beta cyclodextrin, administered intravenously.

Read more


IntraBio Clinical Trial Authorization Application Approved by the MHRA for the Treatment of Niemann-Pick Disease type C (NPC)

IntraBio Clinical Trial Authorization Application Approved by the MHRA for the Treatment of Niemann-Pick Disease type C (NPC): OXFORD, UK, March 11, 2019-- IntraBio Inc., a late-stage biopharmaceutical company, today announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved its Clinical Trial Authorisation (CTA) Application for Clinical Trial IB1001-201 with its lead compound (IB1001) for the treatment of Niemann-Pick disease Type C (NPC).

Read more
View all news Subscribe